Elastomeric Infusion Pumps Market Size & Growth Forecast 2027–2036, By Segments (Product, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Elastomeric Infusion Pumps Market size was around USD 770.43 million in 2026 and is slated to grow at a 6.84% CAGR from 2027 to 2036, attaining USD 1.49 billion by 2036. The industry revenue for 2027 is estimated at USD 814.81 million.
Get more details on this report
Request Free Sample ReportElastomeric Infusion Pumps Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 42.08% share in 2026, driven by established outpatient infusion practices and strong integration across hospitals, ambulatory, and home-based care settings.
- Asia Pacific is expanding at an 8.25% CAGR, supported by rising healthcare access, increasing treatment volumes, and growing adoption of cost-efficient, portable infusion solutions.
Segment Momentum
- Continuous Rate Elastomeric Infusion Pumps held a 62.09% market share in 2026 due to broad clinical familiarity, straightforward operation, and dependable drug delivery for routine pain management, antibiotic therapy, and post-acute care workflows.
- Ambulatory Surgical Centers are growing fastest because they increasingly require portable, easy-to-manage infusion solutions that support outpatient procedures, faster discharge, and continued therapy without adding operational complexity.
Market Expansion Drivers
- Rising prevalence of chronic diseases increasing demand for continuous ambulatory drug delivery systems.
- Expanding home healthcare adoption accelerating utilization of portable infusion pump technologies.
- Favorable reimbursement support for non-opioid pain management boosting infusion therapy adoption.
Leading Market Participants
- Major players in the elastomeric infusion pumps market include Baxter International Inc. (United States), Fresenius Kabi AG (Germany), B. Braun SE (Germany), Terumo Corporation (Japan), Nipro Corporation (Japan), Vygon SAS (France), Leventon, S.A.U. (Spain), Avanos Medical, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 770.43 million
- 2027 Estimated Market Size: USD 814.81 million.
- Projected Market Size: USD 1.49 billion by 2036
- Growth Forecast: 6.84% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Continuous Rate Elastomeric Infusion Pumps (Product) | Hospitals (End-use) | Pain Management (Application)
- Emerging Opportunity Segment: Variable Rate Elastomeric Infusion Pumps (Product) | Ambulatory Surgical Centers (End-use) | Antibiotic/Antiviral Therapy (Application)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic diseases increasing demand for continuous ambulatory drug delivery systems
The growing burden of chronic diseases is supporting the elastomeric infusion pumps market by increasing the need for reliable drug delivery outside conventional inpatient environments. Patients requiring prolonged administration of antibiotics, pain medications, chemotherapy agents, or other therapies can benefit from continuous infusion systems that provide controlled medication delivery over an extended period. Elastomeric pumps are particularly suited to ambulatory treatment because their lightweight and portable design allows patients to maintain greater mobility while receiving therapy. As healthcare providers increasingly seek treatment approaches that reduce unnecessary hospital stays and accommodate longer-duration therapies, demand for practical continuous drug delivery technologies is being reinforced.
Expanding home healthcare adoption accelerating utilization of portable infusion pump technologies
The shift toward home-based care is creating a favorable environment for the elastomeric infusion pumps market as healthcare systems increasingly support treatment outside hospitals and other institutional settings. Portable infusion pumps allow eligible patients to receive prescribed therapies at home while maintaining continuous medication delivery without requiring complex equipment or prolonged clinical supervision. Their compact format can improve patient mobility and support greater flexibility during treatment, making them suitable for selected infusion therapies delivered through home healthcare programs. As providers focus on improving patient convenience and reducing pressure on hospital resources, the integration of portable infusion technologies into home-based treatment pathways is becoming more relevant.
Favorable reimbursement support for non-opioid pain management boosting infusion therapy adoption
Greater support for non-opioid approaches to pain management is encouraging the use of infusion-based therapies in settings where controlled medication delivery is required, benefiting the elastomeric infusion pumps market. These pumps can facilitate continuous administration of selected non-opioid analgesic therapies, including treatment protocols used during postoperative recovery and other pain management applications. Reimbursement coverage can improve patient access to eligible therapies by reducing financial barriers and encouraging healthcare providers to consider ambulatory infusion options within appropriate treatment pathways. As clinicians seek pain management strategies that limit reliance on opioid-based medications while maintaining effective symptom control, portable infusion systems can provide a practical delivery mechanism for prescribed therapies.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of chronic diseases increasing demand for continuous ambulatory drug delivery systems | 2.00% | High | North America, Europe | High | Near Term |
| Expanding home healthcare adoption accelerating utilization of portable infusion pump technologies | 1.80% | Moderate | North America, Asia Pacific | High | Mid Term |
| Favorable reimbursement support for non-opioid pain management boosting infusion therapy adoption | 1.50% | High | North America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the elastomeric infusion pumps market, North America accounted for the largest share of 42.08% in 2026, underpinned by advanced healthcare infrastructure, established home-based care systems, and strong utilization of ambulatory treatment approaches. Demand is supported by the growing preference for portable drug-delivery solutions that can facilitate treatment outside traditional inpatient settings. Well-developed clinical networks and increasing attention to patient convenience and efficient care delivery further contribute to the region's strong market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is witnessing the fastest growth in the elastomeric infusion pumps market as healthcare systems expand and access to advanced drug-delivery technologies improves. Rising demand for cost-efficient and portable treatment solutions is encouraging adoption across hospitals, outpatient facilities, and home-care environments. Growing healthcare expenditure, increasing prevalence of conditions requiring prolonged medication administration, and investments in medical infrastructure are creating favorable conditions for wider use of elastomeric infusion pumps.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Infusion DeliveryGermany emphasizes elastomeric infusion pumps that deliver accurate, reliable drug administration across hospitals and ambulatory care settings. German healthcare facilities increasingly prioritize product quality and consistent infusion performance for long-duration therapies.
France 🇫🇷
Continuous Care SolutionsFrance utilizes elastomeric infusion pumps to support continuous drug delivery across oncology, pain management, and antibiotic therapies. French healthcare providers increasingly seek dependable devices that enhance treatment continuity in both hospital and home care environments.
Italy 🇮🇹
Patient-Centered InfusionItaly adopts elastomeric infusion pumps to expand patient-centered treatment options beyond conventional inpatient care. Italian healthcare facilities increasingly emphasize portable infusion solutions that improve therapy convenience while supporting efficient clinical resource utilization.
Japan 🇯🇵
Home Therapy SupportJapan expands the use of elastomeric infusion pumps as home healthcare and long-term treatment become more common. Japanese healthcare providers increasingly value compact infusion devices that improve patient mobility and simplify therapy management outside hospitals.
South Korea 🇰🇷
Ambulatory Treatment EfficiencySouth Korea integrates elastomeric infusion pumps into ambulatory care to improve treatment flexibility and patient comfort. Healthcare providers increasingly adopt portable infusion technologies that streamline medication delivery while supporting efficient clinical workflows.
United States 🇺🇸
Outpatient Infusion CareThe U.S. elastomeric infusion pumps market supports expanding outpatient treatment and home-based drug administration. Healthcare providers in the U.S. increasingly adopt portable infusion systems that improve patient convenience while reducing dependence on hospital-based care.
Segment Leadership and Growth Trends
Elastomeric Infusion Pumps Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Continuous Rate Elastomeric Infusion Pumps (Largest Segment) vs Variable Rate Elastomeric Infusion Pumps (Fastest-Growing Segment)
Continuous rate elastomeric infusion pumps segment dominated the product category of the elastomeric infusion pumps market, accounting for 62.09% in 2026. Their established position is supported by the ability to deliver medication at a consistent predetermined rate, making these pumps suitable for therapies that require controlled and uninterrupted administration. Their compact, portable design can also support treatment outside traditional inpatient settings, improving convenience for patients while helping healthcare providers manage infusion-based therapies efficiently.
Variable rate elastomeric infusion pumps are anticipated to record the fastest growth as demand increases for infusion systems capable of accommodating treatment protocols that require greater flexibility in medication delivery. Adjustable administration rates can provide healthcare professionals with more control over therapy according to patient and treatment requirements. The growing movement toward personalized care and outpatient treatment is supporting interest in infusion technologies that combine portability with adaptable drug-delivery capabilities.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals held the largest share of the end-use category in the elastomeric infusion pumps market, accounting for 45.83% in 2026. Hospitals perform a broad range of procedures and therapies requiring controlled medication delivery, supporting consistent utilization of elastomeric infusion systems across inpatient and clinical care settings. Their established infrastructure, trained healthcare personnel, and ability to manage complex infusion therapies reinforce hospitals as a key end-use environment.
Ambulatory surgical centers are expected to be the fastest-growing end-use segment as healthcare systems increasingly emphasize shorter treatment pathways, outpatient procedures, and cost-efficient care delivery. Elastomeric infusion pumps are well suited to ambulatory settings because their portable design can facilitate medication administration without requiring patients to remain connected to conventional infusion equipment. The expansion of outpatient care and growing preference for convenient recovery environments are therefore supporting increased adoption within ambulatory surgical centers.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps | Continuous Rate Elastomeric Infusion Pumps | Variable Rate Elastomeric Infusion Pumps |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Application | Pain Management, Chemotherapy, Antibiotic/Antiviral Therapy, Others | Pain Management | Antibiotic/Antiviral Therapy |
Competitive Landscape and Market Positioning
Prominent players in the elastomeric infusion pumps market:
1. Baxter International Inc. (United States)
2. Fresenius Kabi AG (Germany)
3. B. Braun SE (Germany)
4. Terumo Corporation (Japan)
5. Nipro Corporation (Japan)
6. Vygon SAS (France)
7. Leventon S.A.U. (Spain)
8. Avanos Medical Inc. (United States)
Competitive activity in the elastomeric infusion pumps market is being shaped by the introduction of lightweight and user-centric infusion technologies. Market participants are focusing on improving dosage consistency, portability, and infection control capabilities to address growing outpatient care demand. Investments in product refinement and workflow efficiency are also supporting broader adoption across homecare and ambulatory treatment environments.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Baxter International Inc. (United States) | |||||||
| Fresenius Kabi AG (Germany) | |||||||
| B. Braun SE (Germany) | |||||||
| Terumo Corporation (Japan) | |||||||
| Nipro Corporation (Japan) | |||||||
| Vygon SAS (France) | |||||||
| Leventon S.A.U. (Spain) | |||||||
| Avanos Medical Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Penlon | May-25 | Penlon (UK) launched a new range of infusion systems designed for simplified and safer control over therapy delivery in clinical settings. |
| ICU Medical | Apr-25 | ICU Medical received FDA 510(k) clearance for its Plum Solo™ precision IV pump and LifeShield™ infusion safety software, marking a major expansion of its IV performance platform. |
| Supernus Pharmaceuticals | Feb-25 | The FDA approved the ONAPGO (subcutaneous apomorphine infusion device), a significant advancement in delivering precise continuous therapy for motor fluctuations in patients with advanced Parkinson’s disease. |
| Smiths Medical | Aug-24 | Smiths Medical initiated a corrective recall for its CADD-Solis Ambulatory Infusion Pump due to software-related issues, underscoring ongoing industry focus on addressing legacy technology risks in infusion hardware. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Elastomeric Infusion Pumps Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Fill Volume Capacity | Up to 100 mL, 101–250 mL, 251–500 mL, Above 500 mL |
| Therapy Duration | Short-Term Therapy (Up to 24 Hours), Intermediate Therapy (1–7 Days), Extended Therapy (More Than 7 Days) |
| Distribution Channel | Direct Sales, Medical Device Distributors, Hospital & Healthcare Procurement, Online Channels |
Elastomeric Infusion Pumps Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Home Infusion Therapy Market Readiness Assessment |
|
| Ambulatory Care Adoption Opportunity Analysis |
|
| Drug Compatibility and Therapy Mapping |
|
Need a different cut of the data?
Request Custom ResearchHow large is the elastomeric infusion pumps market?
What is the anticipated CAGR of the elastomeric infusion pumps industry?
How is rising chronic disease burden reshaping adoption of elastomeric infusion pumps in ambulatory care models?
Why is the shift toward home healthcare accelerating utilization of elastomeric infusion pump technologies?
Why do Continuous Rate Elastomeric Infusion Pumps lead the elastomeric infusion pumps market?
Why are Ambulatory Surgical Centers the fastest-growing end-use segment in the elastomeric infusion pumps market?
Why does North America lead the elastomeric infusion pumps market?
What is driving growth in Asia Pacific in this market?
Who holds a significant market share in the elastomeric infusion pumps landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization